📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

Moderna Inc DRC (MRNAm)

Buenos Aires
Currency in ARS
Disclaimer
3,635.00
-105.00(-2.81%)
Closed

MRNAm Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa13,6204,981-3,118
Cash from Operations Growth
Net Income
Depreciation & Amortization, Total
Amortization of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-8,523-5,1764,206
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-873-3,448-1,377
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa4,224-3,643-289
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
* In Millions of USD (except for per share items)